@article{3b2d7635dc71493eb408da4015281aef,
title = "Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP∼T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea",
author = "{A3L31 Study Group} and Kim, {Yae Jean} and Jo, {Dae Sun} and Kim, {Hyun Hee} and Kang, {Jin Han} and Kim, {Hee Soo} and Joon Bang and Yongho Oh and Kim, {Yun Kyung} and Emmanuel Vidor and Kim, {Hwang Min} and Shin, {Son Moon} and Lee, {Kyung Yil} and Cha, {Sung Ho} and Ma, {Sang Hyuk} and Kim, {Dong Ho} and Jin Lee and Park, {Su Eun} and Hyunju Lee and Kim, {Jong Duk} and Kim, {Ki Hwan} and Kim, {Kyung Hyo} and Kim, {Jong Hyun}",
note = "Funding Information: This study was supported by Sanofi Pasteur, Lyon, France. Funding Information: The authors acknowledge the study personnel for the conduct of the study and also all enrolled infants and parents/legal guardian(s) for their participation. This manuscript was prepared with the assistance of a professional medical writer, Dr Andrew Lane (Lane Medical Writing), in accordance with the European Medical Writers Association guidelines and Good Publication Practice. This study was funded by Sanofi Pasteur. ",
year = "2017",
month = jul,
day = "13",
doi = "10.1016/j.vaccine.2017.05.062",
language = "English",
volume = "35",
pages = "4022--4028",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "32",
}